50 research outputs found
5.7 The Input of Home Telemonitoring for the Treatment of Chronic Heart Failure in Old People at High Risk
n/
Controllo del rischio cardiovascolare e terapia comportamentale nel paziente anziano iperteso
The primary goal of treatment of the patient with high blood pressure is to achieve the maximum reduction in the long-term total risk of cardiovascular mortality and morbidity. This is possible only treating all the reversible risk factors identified, including smoking, dyslipidaemia and diabetes. Lifestyle changes should be instituted in all patients, in particular in hypertensive patients, with the purpose of lowering blood pressure and of controlling risk factors and clinical conditions present. The changes in lifestyle measures that are considered necessary to lower blood pressure or cardiovascular risk and that should be considered are smoking cessation, weight reduction, physical exercise, reduction of alcohol and salt intake and increase in fruit and vegetable intake
Costo e prescrizione dei farmaci antiipertensivi in Regione Lombardia nel triennio 2004-06. terapia di associazionecome opportunità di risparmio
Il contributo della telemedicina nel trattamento dello scompenso cardiaco cronico nell’anziano ad alto rischio
Il contributo della telemedicina nel trattamento dello scompenso cardiaco cronico nell'anziano ad alto rischio
Correlation between left ventricular mass and blood pressure in patients aged over 90 years
L'ipertensione sistolica isolata nell'anziano
Isolated systolic hypertension is common in the elderly and is closely linked to cerebro-vascular events and acute coronary events. Several trials have shown that treating isolated systolic hypertension decreased cardiovascular morbidity and mortality. Thiazide diuretics and dihydropyridine calcium antagonists are the primary agents used in these trials, supplemented with \u3b2 blockers or RAAS inhibitors as needed. Lifestyle modification and pharmacologic treatment are the main modalities for treating isolated systolic hypertension in the elderly. However, the morbidity and mortality benefit of treating isolated systolic hypertension in the very old (individuals above the age of 80) remains to be established